Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of prostatic diseases. It inhibits PTP1B activity in a dose-dependent manner with IC50 values of 51.5 uM, suggest that atraric acid has potential to treat diabetes.
Molecular Weight:
196.2
Purity:
99.27%
CAS Number:
[4707-47-5]
Formula:
C10H12O4
Target:
NO Synthase|||Androgen Receptor|||Phosphatase|||NF-kappaB|||p38 MAPK
TCS1372
* VAT and and shipping costs not included. Errors and price changes excepted
